Repair Biotechnologies is a preclinical biotechnology company focused on developing drugs for cholesterol and aging-related diseases. Our first-in-class Cholesterol Degrading Platform (CDP) technology is aimed at reversing atherosclerosis, familial hypercholesterolemias, and other conditions in which excess or modified cholesterol drives pathology.
Location: United States, New York, Syracuse
Member count: 1-10
Total raised: $2.15M
Founded date: 2018
Investors 2
| Date | Name | Website |
| - | Grapeseed.... | grapeseed.... |
| - | Bioverge | ventures.b... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 07.05.2019 | Seed | $2.15M | - | finsmes.co... |
Mentions in press and media 5
| Date | Title | Description | Category | Author | Source |
| 08.05.2019 | Term Sheet... | THE $1 BILLION LOSS 2019 will... | - | - | fortune.co... |
| 07.05.2019 | Repair Bio... | Repair Biotechnologies, Inc., ... | USA | - | finsmes.co... |
| 07.05.2019 | Repair Bio... | SYRACUSE, NY, Repair Biotech... | - | - | vcnewsdail... |
| 07.05.2019 | Repair Bio... | SYRACUSE, N.Y.--(BUSINESS WIRE... | - | - | citybizlis... |
| - | Repair Bio... | “Human cells cannot degrade ch... | - | - | fastfounde... |